// App-Quantinova.ai

TCT-180 : Impact of Chronic Obstructive Pulmonary Disease in Patients with Left Main Disease Randomized to PCI vs. CABG: A Propensity Score Matched Analysis From the EXCEL Trial

Researchers

Presenter

  • Xin Huang

Principal Investigators

  • Bjorn Redfors

  • Shmuel Chen

  • Yangbo Liu

  • Ori Ben-Yehuda

  • David Kandzari

  • Roxana Mehran

  • Ad Van Boven

  • Piet Willem Boonstra

  • Joseph Sabik

  • Patrick Serruys

  • A. Pieter Kappetein

  • Gregg Stone

Medical Centers

  • Piedmont Heart Institute, Atlanta, Georgia, United States

  • Imperial College, London, United Kingdom

  • Cardiovascular Research Foundation, NY, Armenia

  • Zena and Michael A. Wiener Cardiovascular Institute, Mount Sinai Hospital, New York, New York, United States

  • Department of Cardiothoracic Surgery, Erasmus University Medical Center, Rotterdam, Netherlands

  • CRF, New York, New York, United States

  • Cardiovascular Research Foundation, New York, New York, United States

  • Medisch Centrum Leeuwarden, Haren, Netherlands

  • Medisch Centrum Leeuwarden, Heart Center, Leeuwarden PObox 888, Netherlands

  • Department of Thoracic and Cardiovascular Surgery, The Cleveland Clinic Foundation, Cleveland, Ohio, United States

Locations

  • United States

  • Netherlands

  • Armenia

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

Disease

  • Chronic obstructive pulmonary disease

  • Left main disease

Biomarkers

  • N/A

Drug/Treatment

  • Everolimus

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved